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Recent advances in somatic cell reprogramming
have highlighted the plasticity of the somatic epige-
nome, particularly through demonstrations of direct
lineage reprogramming of one somatic cell type to
another by defined factors. However, it is not clear
to what extent this type of reprogramming is able to
generate fully functional differentiated cells. In addi-
tion, the activity of the reprogrammed cells in cell
transplantation assays, such as those envisaged for
cell-based therapy of Parkinson’s disease (PD),
remains to be determined. Herewe show that ectopic
expression of defined transcription factors in mouse
tail tip fibroblasts is sufficient to induce Pitx3+
neurons that closely resemble midbrain dopami-
nergic (DA) neurons. In addition, transplantation of
these induced DA (iDA) neurons alleviates symptoms
in a mouse model of PD. Thus, iDA neurons gener-
ated from abundant somatic fibroblasts by direct
lineage reprogramming hold promise for modeling
neurodegenerative disease and for cell-based thera-
pies of PD.
Parkinson’s disease (PD) is one of the most common neurode-
generative disorders and is characterized by a loss of dopami-
nergic (DA) neurons, primarily of the substantia nigra pars
compacta (SN), leading to a reduction of dopamine in the stria-
tum (Berke and Hyman, 2000; Huse et al., 2005). While several
possible cell sources, including fetal brain cells, ESCs, and
iPSCs, are being explored as cell replacement therapies for de-
generating DA neurons, ethical and practical barriers to the
application of such therapies exist (Kim et al., 2002; Olanow
et al., 1996; Wernig et al., 2008). Epigenetic reprogramming to
pluripotency has provided critical evidence for the plasticity of
the somatic genome (Eggan et al., 2004; Wilmut et al., 1997),
and recent studies have demonstrated the feasibility of direct
lineage reprogramming from one somatic cell type to another,
bypassing a pluripotent intermediate state (Ieda et al., 2010;
Szabo et al., 2010; Vierbuchen et al., 2010; Zhou et al., 2008).CelTwo recent studies reported the generation of DA neurons by
direct reprogramming (Caiazzo et al., 2011; Pfisterer et al.,
2011). However, in these studies the gene expression profiles
of reprogrammed DA neurons differed significantly from primary
midbrain DA neurons. Furthermore, induced DA (iDA) neurons
were not shown tobe functional by in vivo transplantation assays.
Thus, to assess the therapeutic potential of lineage-converted
cells, we examined whether alternative induction strategies
could generate iDA neurons that resemble midbrain DA neurons
more closely and are functional in transplantation assays.
To analyze fibroblast reprogramming to DA neurons, we
generated a knockin (KI) mousemodel in which the eGFP coding
sequence was targeted to the Pitx3 gene under control of the
endogenous promoter (Pitx3-eGFP) (Figures S1A and S1B avail-
able online). Previously, GFP+ cells derived from Pitx3-eGFP KI
ESCs and mice have been shown to be functional midbrain DA
neurons and to effectively alleviate symptoms in PD animal
models (Hedlund et al., 2008; Zhao et al., 2004), while other
reporter systems such as tyrosine hydroxylase (TH)-GFP were
less effective (Hedlund et al., 2007). eGFP expression in DA
neurons was assessed after in vitro differentiation of Pitx3-
eGFP ESCs, and adult mice generated from Pitx3-eGFP ESCs
exhibited eGFP+DA neurons in themidbrain that were also posi-
tive for TH, a marker of mature DA neurons (Figures S1C and
S1D). These data show that the Pitx3-eGFP KI model faithfully
induced eGFP expression in midbrain DA neurons, thus
providing a useful system for the isolation of iDA neurons.
To exclude the possibility of progenitor cell contamination in
preparations of embryonic fibroblasts, we prepared tail tip fibro-
blasts (TTFs) from adult Pitx3-eGFP mice, which were GFP and
TH negative (Figures 1A and 1B, top right). A group of 11 candi-
date transcription factors was selected based on their known
functions in the development and survival of midbrain DA
neurons (Table S1 available online), and was packaged into
doxycycline (dox)-inducible lentiviruses and introduced into
Pitx3-eGFP TTFs. Twelve days after infection, TH+ cells with
neuronal morphology appeared in the cultures (Figure 1B,
middle left and bottom panels) with eventually approximately
2% of the cells expressing Pitx3 as indicated by eGFP staining
(Figure 1C). We also reprogrammed wild-type TTFs as indicated
by the appearance of DA neuron-like cells after viral transduction
(Figure 1B,middle right). To determinewhich factors were criticall Stem Cell 9, 413–419, November 4, 2011 ª2011 Elsevier Inc. 413
Figure 1. Direct Conversion of Fibroblasts into Functional DA Neurons
(A) Strategy for lineage reprogramming of iDA neurons from Pitx3-eGFP TTF. TTFs were transduced with lentiviral pools encoding 11 transcription factors, and
cultured for 10 days in dox-containing N3 media.
(B) Morphology and immunofluorescence for TH+ DA neuron-like cells (red) in fibroblasts transduced with 11 transcription factors (top left panel). No TH+/GFP+
signal can be seen in control fibroblasts lacking M2rtTA (top right panel). TH+ DA neuron-like cells were detected in 11-factor-infected Pitx3-eGFP fibroblasts
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tested the ability of different combinations of the pools to induce
Pitx3-eGFP. Using this subtractive approach we found that a
pool of eight factors lacking Pax6, Sox1, and Ngn2 generated
Pitx3-eGFP+ cells more efficiently than the original pool of 11,
whereas removal of the Acsl1, Myt1l, or Brn2 group or the
Lmx1a, Lmx1b, Nurr1, Pitx3, or EN1 group failed to produce
Pitx3-eGFP+ cells, suggesting that this combination of eight
transcription factors was sufficient for the induction of Pitx3-
eGFP+ cells (Figure S1E). To identify the key DA-inducing
factors, we examined the effects of removing individual factors
from the eight-factor pool. Surprisingly, eGFP+ cells were not
detectable in TTF cultures infected with lentiviral pools lacking
Ascl1, and pools lacking Pitx3 induced only a small number of
eGFP+ cells (about 0.5%). However, pools lacking any of the re-
maining six factors were able to induce significant numbers of
eGFP+ cells (Figure S1F). This result suggests that Ascl1 and
Pitx3 are necessary for the induction of Pitx3-eGFP+ DA
neurons. We also found that these two transcription factors
alone were able to induce Pitx3-eGFP+ cells in 2%–3% of the
target cells (Figure 1D). The expression of DA neuronal marker
genes was determined using quantitative RT-PCR on FACS-
purified Ascl1/Pitx3 transduced GFP+ and GFP cells. The
DA-neuron-specific markers examined included genes involved
in the biosynthesis of dopamine [TH, aromatic L-amino acid de-
carboxylase (AADC)], dopamine storage [vesicular monoamine
transporter 2 (VMAT2)], and dopamine uptake [dopamine trans-
porter (DAT)], all of which were significantly upregulated in
Pitx3-eGFP+ cells when compared to eGFP cells (Figure 1E).
However, the expression level of these genes was lower than
that observed in primary Pitx3-eGFP+ DA neurons (Figure S1G)
andwewere not able to detect dopamine or electrophysiological
activity (data not shown). Wemaintained the eGFP+ cell cultures
for up to 4 weeks and did not observe significant maturation of
DA neurons (data not shown). These results suggest that Pitx3-
eGFP+ cells induced by Ascl1 and Pitx3 are not terminally differ-
entiated DA neurons but may instead represent immature DA
neurons. Several extrinsic and intrinsic factors that control matu-
ration of DA neurons are functionally interconnected and coop-
erate to promote the terminal differentiation of DA neurons
during neuronal development (Kim et al., 2002; Lee et al.,
2000; Martinat et al., 2006). We therefore tested whether inclu-
sion of additional factors could fully reprogram fibroblasts into
functional DA neurons.
Several neurotrophic factors including Sonic hedgehog (Shh)
and Fibroblast growth factor 8 (FGF8) appear to be critical for
the specification and differentiation of developing midbrain DA
neurons (Lee et al., 2000). To examine whether Shh and FGF8
promote DA neuron reprogramming, Ascl1 and Pitx3 transduced(middle left panels), which are double-labeled with GFP (bottom panels). TH+ DA
(middle right panel). Scale bars = 100 mm.
(C) Flow cytometry analysis for induction of eGFP+ cells from Pitx3-eGFP TTFs tr
shown (top panel).
(D) Induction of eGFP+ cells from Pitx3-eGFP TTFs by the ectopic expression of
(E) Quantitative RT-PCR of the expression of DA-neuron marker genes on FACS-p
the expression of DA-neuron-specific genes was significantly upregulated in eG
performed; ANOVA test, *p < 0.05.
(F) Immunostaining of iDA neurons for the mature neuronal and DA neuronal ma
(G) FACS analysis for eGFP induction from Pitx3-eGFP TTFs transduced with six
Celfibroblasts were cultured with Shh and FGF8 and the efficiency
of iDA neuron generation was determined. Cultures treated
with Shh and FGF8 generated about 5% Pitx3-eGFP+ cells,
which is 2-fold more than in cultures treated with bFGF alone
(Figure S1H). These data suggest that neurotrophic factors are
critical components in promoting the generation of iDA neurons
from fibroblasts. We also examined the DA-neuron-inducing
activity of other genes by adding single factors to the Ascl1/
Pitx3-infected cells. As shown in Figure S1I, the addition of
Lmx1a, Nurr1, Foxa2, and EN1 in combination with Ascl1 and
Pitx3 significantly enhanced the efficiency of eGFP+ induction,
whereas overexpression of Sox1, Pax6, or Lmx1b had an inhib-
itory effect or no effect at all. Because of the positive effects of
Lmx1a, Nurr1, Foxa2, and EN1 on the reprogramming process,
we tested different combinations of these four factors along
with Ascl1 and Pitx3 and found that the combination of all six
factors (Ascl1, Pitx3, Lmx1a, Nurr1, Foxa2, and EN1) gave rise
to the highest induction of eGFP+ cells 10 days after infection
(Figure S1J). In addition, these six factors can induce the expres-
sion of DA neuronal marker genes more efficiently than any
other combinations including the previously published three-
factor combinations (Figure S1K), suggesting that the induced
cells resemble midbrain DA neurons more closely than those
generated using other factor combinations. Next, we examined
reprogramming efficiency by flow cytometry on days 4, 8, 12,
and 18 after viral transduction with six factors in combination
with FGF8 and Shh. A significant number of eGFP+ cells were
evident as early as day 4, reaching 8%by day 12 and amaximum
of 9.1%of total cells by day 18 (Figure 1G). Additionally, Figure 1F
shows that TH+ iDA neurons are positive for neuron-specific
class III beta-tubulin (Tuj1) and microtubule-associated protein
2 (MAP2), both mature neuronal makers, and for DAT or AADC,
which are markers of mature DA neurons. Furthermore, none
of the TH+ cells coexpressed dopamine beta hydrolase (DBH),
a marker for noradrenergic neurons. Other types of neurons
including 5HT and motor neurons were also not detected in
these cultures (data not shown).
We compared the gene expression profiles of two- and six-
factor reprogrammed iDA neurons, fibroblasts, neural stem cells
(NSCs), embryonic midbrain DA neurons, and adult midbrain DA
neurons by quantitative RT-PCR (Figure 2A). While some vari-
ability in marker gene expression was seen, likely as a result of
the inconsistent efficiency of viral infection, DA neuronal maker
genes were significantly upregulated in six-factor-induced
GFP+ cells and partially upregulated in two-factor-induced
eGFP+ cells. We also observed induction of NSC markers,
including Nestin, in two-factor-induced Pitx3-eGFP+ cells, but
the expression of these genes was significantly lower in six-
factor-induced Pitx3-eGFP+ cells. These results again suggestneuron-like cells (red) were detected from TTFs derived from wild-type mice
ansduced with 11 transcription factors (bottom panel). Control infection is also
only two factors, Ascl1 and Pitx3.
urified, Ascl1/Pitx3-induced eGFP+ and eGFP cells. Ten days after infection,
FP+ cells. Data represent mean ± SEM; three independent experiments were
rkers Tuj1, MAP2, DAT, and AADC. Scale bars = 100 mm.
reprogramming factors after 4, 8, 12, and 18 days.
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Figure 2. Functional Characterizations of iDA Neurons
(A) Gene expression profiling using quantitative RT-PCR analysis of neuronal, DA neuronal, ESC, and fibroblastmarker gene expression in fibroblasts, NSCs, two-
and six-factor-induced DA neurons, and primary embryonic and adult midbrain DA neurons. Rows represent the evaluated genes and heat map represents the
relative expression of genes as indicated.
(B) Detection of dopamine from iDA neurons by RP-HPLC. The six-factor-infected cell cultures were analyzed 15 days after viral transduction and significant
amounts of DA and the DA derivative 3,4 dihydroxyphenylactic acid (DOPAC) were detected in the six-factor-induced DA neurons.
(C–E) Electrophysiological properties of iDA neurons. (C) Representative recording of action potentials recorded from an iDA neuron. Bottom traces represent
current injections (20 pA to +120 pA), whereas top traces indicate voltage recordings. (D) Voltage-dependent membrane currents and depolarizing voltage
Cell Stem Cell
Functional Integration of iDA Neurons from TTFs
416 Cell Stem Cell 9, 413–419, November 4, 2011 ª2011 Elsevier Inc.
Cell Stem Cell
Functional Integration of iDA Neurons from TTFsthat two-factor-induced Pitx3-eGFP+ cells represent immature
DA neurons and that additional factors are required for the matu-
ration of two-factor-induced eGFP+ cells into differentiated DA
neurons. Furthermore, we found a significant reduction of fibro-
blast marker gene expression in six-factor-induced eGFP+ cells
to levels indistinguishable from those seen in primary Pitx3-
eGFP+ cells. These results indicate that six-factor iDA neurons
are similar at the molecular level to midbrain DA neurons. The
dependence of iDA neurons on ectopic transgene expression
was examined using a dox-inducible lentiviral system. We trans-
duced Pitx3-eGFP TTFs with the dox-inducible factors along
with M2rtTA and induced iDA neuron reprogramming with dox
for 5 days. After eGFP expression was detected in the reprog-
ramming cultures, dox was withdrawn and the cells were main-
tained for 7 days to allow complete silencing of exogenous gene
expression (Figure S2A). We observed that Pitx3-eGFP expres-
sion was stably maintained in these cultures, demonstrating
that the iDA neurons are phenotypically stable in the absence
of ectopic factor expression (Figure S2B).
To test whether the reprogrammed cells have functional qual-
ities of DA neurons, we examined dopamine production by
reverse-phase high performance liquid chromatography (RP-
HPLC). Significant levels of dopamine and the dopamine deriva-
tive 3,4 dihydroxyphenylactic acid (DOPAC) were detected in the
iDA neurons (Figure 2B), in contrast to fibroblasts, which were
negative for this derivative (Figure S2C). Importantly, we were
able to detect dopamine release in the context of high potassium
(56 mM)-induced depolarization in the iDA neurons (Figure S2D),
as expected for functional neurons that produce and release
dopamine. We also examined whether iDA neurons display
electrophysiological properties characteristic of DA neurons.
iDA neurons exhibiting a differentiated DA neuronal morphology
were analyzed using whole-cell patch-clamp analysis and
the identity of the analyzed cells was retrospectively confirmed
by TH immunostaining. A current step protocol (20 pA
to +120 pA) elicited long-duration action potentials (>2 ms) in
the majority of reprogrammed iDA neurons (13 out of 20 cells)
(Figure 2C), in contrast to control fibroblasts, which were nega-
tive (Figure S2E). Fifteen days after dox treatment, the average
resting membrane potential of iDA neurons was 48.23 ± 7.25 mVsteps elicited fast inward sodium currents (bottom traces, magnified inset) and
dotoxin (TTX) on action potential of iDA neurons. Top panel: iDA neuron before TTX
current injections ranged from100 pA to +200 pA in 10mV steps. TTX completely
neurons.
(F–H) Quantification of membrane properties in iDA neurons at 15 days after infe
presented as mean ± SEM. RMP, resting membrane potentials; AP, action poten
(I) Amphetamine-induced (4 mg/kg) rotational behaviors for 90 min in 6OHDA
transplantation of Pitx3-eGFP+ cells (about 50,000 cells), control fibroblasts (sham
striatum. Transplantation of reprogrammed Pitx3-eGFP+ cells and primary embry
rotation scores in 6OHDA lesionedmice 8 weeks after transplantation. None of the
experiments (control fibroblasts) showed reduced rotation (n = 12). Data represe
(J) Statistical analysis of amphetamine-induced rotational behaviors 8 weeks aft
(K) Substantial graft-derived reinnervation of the lesioned striatum 8 weeks after tr
into the striatum of 6OHDA lesioned adult mice. The boxed area in (K) is shown at
lesioned striatum is shown, and most of the TH+ neurons show a large size and
(L) The grafted GFP+ cells coexpressed TH and another DA neuronal maker, AA
(M) Total TH+ cells in the graft (n = 5). Five brain slices with 50 mm thickness arou
*p < 0.05.
(N) Summary of HPLC quantification of dopamine levels in both iDA neuron-transp
*p < 0.05.
Cel(mean ± SEM, n = 13), the input resistance was 1.13 ± 0.38 GU
(mean ± SEM, n = 13), and action potential amplitude was
84.23 ± 18.69 mV (mean ± SEM, n = 13), providing evidence
that the electrophysiological properties of the iDA neurons are
similar to those of midbrain DA neurons (Figures 2F–2H). The
iDA neurons also exhibited voltage-dependent ionic currents
(Figure 2D). In addition, the action potentials evoked by depola-
rizing current injections in iDA neurons (top panel) were com-
pletely abolished by TTX administration (bottom panel) (Fig-
ure 2E), indicating the presence of well-developed Na channels
in iDA neurons. Furthermore, in current-clamp mode we were
able to inject prolonged hyperpolarizing current pulses (+20 pA
to 140 pA) and observed that the voltage responses started
to decline slowly in an iDA neuron (Figure S2F); this type of prom-
inent time-dependent anomalous rectification is characteristic of
the functional midbrain DA neurons (Rayport et al., 1992). In sum,
these results indicate that the reprogrammed DA-producing
neurons acquired functional properties that are highly similar to
those of midbrain DA neurons.
Finally, we investigated whether iDA neurons can be effective
in a rodent PD model for cell transplantation therapy. Pitx3-
eGFP+ cells were FACS isolated from TTFs 12 days after trans-
duction with six factors. The eGFP+ cells were implanted into the
striatum of mice that had been lesioned with 6-hydroxydop-
amine (6OHDA) to mimic the DA loss that occurs in PD. Eight
weeks after transplantation, the implanted Pitx3-eGFP+ cells
led to a significant reduction in amphetamine-induced rotation
scores in 6OHDA lesioned mice (Figures 2I and 2J) in contrast
to sham transplanted or intact controls, which showed no
rescue. The survival of the transplanted iDA neurons was as-
sessed in sections stained for TH (Figure 2K). In control mice,
complete loss of TH fibers in the striatum occurred 4 weeks
after 6OHDA lesioning (Figure S2G), but mice transplanted with
Pitx3-eGFP+ cells exhibited integrated grafts containing large
numbers of DA neurons (350–1900 cells, Figure 2M). The grafted
cells showed neuronal morphology and extended TH+ fibers into
the deinnervated host striatum (Figure 2K). We confirmed that all
transplanted eGFP+ cells expressed the DA neuron markers
TH and AADC in vivo (Figure 2l), and elevated dopamine levels
were detected in transplanted striatum (Figure 2N). These dataslow inactivating outward potassium currents (top traces). (E) Effect of tetro-
application. Bottompanel: same neuron after treatment with TTX. Depolarizing
inhibited the action potential evoked by depolarization current injections in iDA
ction. Numbers in the bars represent the numbers of recorded cells. Data are
tial; Rin, membrane input resistances.
lesioned mice before the cell transplantation, and 4 and 8 weeks after the
controls), and primary embryonicmidbrain Pitx3-eGFP+ cells into the lesioned
onic Pitx3-eGFP+ cells led to a significant reduction in amphetamine-induced
intact controls (6OHDA lesioned, but not recipients of cell transplants) or sham
nt mean ± SEM; ANOVA test, *p < 0.05.
er transplantation. Data represent mean ± SEM; ANOVA test, *p < 0.05.
ansplantation. FACS-purified, Pitx3-eGFP+ cells were sorted and transplanted
larger magnification to the left. Partial rescue of TH+ cells and fibers in 6OHDA
elongated shape typical of midbrain DA neurons.
DC. Scale bars = 100 mm.
nd the lesioned site were counted. Data represent mean ± SEM; ANOVA test,
lanted and control striatum. Data represent mean ± SEM, (n = 5); ANOVA test,
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of DA neurons after transplantation and demonstrate the func-
tional capacity of the iDA neurons, suggesting that this type of
strategy may potentially provide a useful therapeutic cell source
for cell replacement therapy in PD.
In this study, we have demonstrated that the combined activity
of Ascl1 and Pitx3 is sufficient to facilitate the conversion of fibro-
blasts into an immature DA neuronal cell fate, and that ectopic
expression of additional transcription factors is required for
maturation of two-factor-induced Pitx3-eGFP+ cells. Reprog-
ramming to pluripotency is thought to involve numerous rounds
of cell division, which appear to be critical for the completion of
epigenetic changes associated with the acquisition of pluripo-
tency (Hanna et al., 2009). In contrast, the reprogramming into
functional neurons does not seem to require multiple cell divi-
sions (Vierbuchen et al., 2010), and differentiated neurons are
postmitotic. Thus, we hypothesized that induction of a functional
DA neuron state might require the activity of additional factors.
Consistent with this idea, we found that the addition of several
other transcription factors to the original two-factor cocktail re-
sulted in the upregulation of mature DA neuronal marker genes
in Pitx3-eGFP+ cells. However, the expression levels of these
DA genes did not reach the same level that is observed in primary
Pitx3-GFP+ cells. Therefore, future studies need to be per-
formed to identify additional DA-neuron-inductive factors, and
possibly epigenetic modifiers, that can generate terminally
differentiated iDA neurons indistinguishable from midbrain DA
neurons. More importantly, we have shown the functional rescue
of iDA neurons in 6OHDA lesioned PD animal models. Although
amphetamine-induced rotational tests do provide a functional
readout, this assay does not measure a clinical phenotype of
PD. Thus, the ability of the iDA neurons to suppress Parkinson-
like symptoms in other behavioral tests remains to be examined.
Moreover, the number of cells with DA phenotype in the present
grafts (350–1900) is considerably higher than the number esti-
mated to be needed in grafts of mouse fetal DA neurons to
compensate for amphetamine administration in 6OHDA lesioned
mice (25–100 DA cells; Brundin et al., 1986). Thus, the functional
efficacy of the mouse-fibroblast-derived iDA neurons described
here appears to be relatively low, suggesting that the reprogram-
ming procedure would need to be improved further to be of use
in cell replacement strategies.
Our results have several implications for the potential use of
iDA neurons for disease modeling and cell replacement therapy
of PD. The generation of iDA neurons from abundant somatic
cells such as fibroblasts in a short period of time makes this
systemattractive for autologouscell-basedapproaches. Further-
more, iDAneuronscouldprovide amore homogenous cell source
for modeling PD in vitro. Importantly, our approach avoids con-
cerns surrounding the inherent tumorigenicity of ESCs or iPSCs
when transplanted in an undifferentiated state. Therefore, the
generation of iDA neurons could provide a reasonable cell source
for pharmacological assays or cell replacement therapy for PD.SUPPLEMENTAL INFORMATION
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